Sale!

MED13L Gene Transposition of the Great Arteries Dextro-Looped 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “MED13L Gene Transposition of the Great Arteries Dextro-Looped 1 Genetic Test” is a specialized diagnostic examination aimed at identifying mutations in the MED13L gene, which have been associated with congenital heart defects, particularly Transposition of the Great Arteries (d-TGA). This condition is characterized by an abnormal arrangement of the two main arteries leaving the heart, leading to insufficient oxygenation of blood throughout the body. The test plays a crucial role in early detection and management of the condition, providing essential information for healthcare providers to devise appropriate treatment plans.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test employs advanced genetic sequencing techniques to accurately analyze the MED13L gene for any abnormalities that may contribute to the development of d-TGA. With a cost of 4400 AED, the test represents a significant investment in the health and well-being of individuals at risk of or suspected to have this congenital heart defect. Through early and precise diagnosis, affected families can access targeted interventions and counseling, potentially improving outcomes and quality of life for those impacted by this condition.

Description

MED13L Gene Transposition of the great arteries dextro-looped 1 Genetic Test

Test Name: MED13L Gene Transposition of the great arteries dextro-looped 1 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Dysmorphology

Doctor: Pediatrics

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for MED13L Gene Transposition of the great arteries, dextro-looped 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MED13L Gene Transposition of the great arteries, dextro-looped 1 NGS Genetic DNA Test gene MED13L

Test Details: The MED13L gene is a gene that provides instructions for making a protein called mediator complex subunit 13-like (MED13L). This protein is involved in regulating the activity of other genes, particularly those involved in the development and function of various organs and tissues. Transposition of the great arteries (TGA) is a congenital heart defect where the two main arteries that carry blood away from the heart, the pulmonary artery and the aorta, are switched in position. This can disrupt the normal flow of oxygenated blood to the body, leading to a variety of symptoms and complications. Dextro-looped 1 is a subtype of TGA where the aorta is positioned on the right side of the heart instead of the left side, and the pulmonary artery is positioned on the left side instead of the right side. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes or even the entire genome at once. This allows for a comprehensive analysis of an individual’s genetic information and can help identify specific genetic variants or mutations that may be associated with a particular condition, such as TGA. In the context of TGA, a NGS genetic test targeting the MED13L gene may be used to identify any genetic variants or mutations within this gene that could potentially contribute to the development of dextro-looped 1 TGA. By identifying these genetic changes, healthcare professionals can gain a better understanding of the underlying causes of the condition and potentially develop more targeted treatment approaches in the future.

Test Name	MED13L Gene Transposition of the great arteries dextro-looped 1 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Dysmorphology
Doctor	Pediatrics
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for MED13L Gene Transposition of the great arteries, dextro-looped 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MED13L Gene Transposition of the great arteries, dextro-looped 1 NGS Genetic DNA Test gene MED13L
Test Details	The MED13L gene is a gene that provides instructions for making a protein called mediator complex subunit 13-like (MED13L). This protein is involved in regulating the activity of other genes, particularly those involved in the development and function of various organs and tissues. Transposition of the great arteries (TGA) is a congenital heart defect where the two main arteries that carry blood away from the heart, the pulmonary artery and the aorta, are switched in position. This can disrupt the normal flow of oxygenated blood to the body, leading to a variety of symptoms and complications. Dextro-looped 1 is a subtype of TGA where the aorta is positioned on the right side of the heart instead of the left side, and the pulmonary artery is positioned on the left side instead of the right side. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes or even the entire genome at once. This allows for a comprehensive analysis of an individual’s genetic information and can help identify specific genetic variants or mutations that may be associated with a particular condition, such as TGA. In the context of TGA, a NGS genetic test targeting the MED13L gene may be used to identify any genetic variants or mutations within this gene that could potentially contribute to the development of dextro-looped 1 TGA. By identifying these genetic changes, healthcare professionals can gain a better understanding of the underlying causes of the condition and potentially develop more targeted treatment approaches in the future.